PA28γ has been shown to enhance cell survival in an in vitro model of Huntington’s disease (HD), a neurodegenerative syndrome caused by a mutation that leads to an abnormally long polyglutamine (polyQ) expansion in the huntingtin (Htt) protein [127]. Here, HTT is linked to juvenile Huntington disease.